603718 Stock Overview
Researches, develops, produces, and sells veterinary biological products for livestock and poultry in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Shanghai Hile Bio-Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.06 |
| 52 Week High | CN¥11.87 |
| 52 Week Low | CN¥5.74 |
| Beta | 1 |
| 11 Month Change | -1.78% |
| 3 Month Change | -26.37% |
| 1 Year Change | -37.46% |
| 33 Year Change | -57.11% |
| 5 Year Change | -50.12% |
| Change since IPO | 42.08% |
Recent News & Updates
There May Be Some Bright Spots In Shanghai Hile Bio-Technology's (SHSE:603718) Earnings
May 06
Earnings Not Telling The Story For Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718)
Apr 29Shareholder Returns
| 603718 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.5% | -5.9% | -3.0% |
| 1Y | -37.5% | -17.9% | -21.8% |
Return vs Industry: 603718 underperformed the CN Pharmaceuticals industry which returned -17.9% over the past year.
Return vs Market: 603718 underperformed the CN Market which returned -21.8% over the past year.
Price Volatility
| 603718 volatility | |
|---|---|
| 603718 Average Weekly Movement | 6.3% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 603718's share price has been volatile over the past 3 months.
Volatility Over Time: 603718's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 295 | James Chen | www.hile-bio.com |
Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis. It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease, and avian infectious bronchitis combined live vaccines.
Shanghai Hile Bio-Technology Co., Ltd. Fundamentals Summary
| 603718 fundamental statistics | |
|---|---|
| Market cap | CN¥3.99b |
| Earnings (TTM) | CN¥44.92m |
| Revenue (TTM) | CN¥239.79m |
88.8x
P/E Ratio16.6x
P/S RatioIs 603718 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603718 income statement (TTM) | |
|---|---|
| Revenue | CN¥239.79m |
| Cost of Revenue | CN¥131.56m |
| Gross Profit | CN¥108.24m |
| Other Expenses | CN¥63.32m |
| Earnings | CN¥44.92m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 31, 2024
| Earnings per share (EPS) | 0.068 |
| Gross Margin | 45.14% |
| Net Profit Margin | 18.73% |
| Debt/Equity Ratio | 5.9% |
How did 603718 perform over the long term?
See historical performance and comparison